Spire Healthcare Group (LON:SPI) Trading Up 17.3% - Here's Why

Key Points

• Spire Healthcare Group shares surged by 17.3%, reaching GBX 253.95 ($3.44) during trading, significantly increasing trading volume to 38,765,020 shares.
• Research analysts maintain a consensus "Buy" rating for Spire, with a reported average price target of GBX 294.33, despite some fluctuating targets from different analysts.
• The company has a debt-to-equity ratio of 62.25 and reported earnings per share (EPS) of GBX 4.10 for the last quarter, indicating a net margin of 1.96%.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shares were up 17.3% during mid-day trading on Friday . The stock traded as high as GBX 254.50 ($3.43) and last traded at GBX 253.95 ($3.42). Approximately 38,765,020 shares were traded during trading, an increase of 2,280% from the average daily volume of 1,628,513 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analysts Set New Price Targets

Several equities research analysts have issued reports on SPI shares. JPMorgan Chase & Co. lowered their target price on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a research note on Tuesday, August 5th. Berenberg Bank reissued a "buy" rating and set a GBX 280 price target on shares of Spire Healthcare Group in a research report on Thursday, July 31st. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of GBX 294.33.

Spire Healthcare Group Price Performance

The stock has a fifty day moving average of GBX 218.75 and a 200-day moving average of GBX 203.55. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The stock has a market capitalization of £947.58 million, a price-to-earnings ratio of 5,119.57, a P/E/G ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, equities research analysts predict that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.